Odyssey Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
51 Sleeper St, Boston, Massachusetts, 02...Phone Number
(617) 865-9628Website
www.odysseytx.comRevenue
<$5 MillionStock Symbol
ODTXIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
3
3
1
1
1
About Odyssey Therapeutics
Odyssey Therapeutics is a biotechnology company developing precision medicines for autoimmune and inflammatory diseases. The company focuses on targeting early immune signals that drive harmful inflammation, aiming to prevent disease before it progresses. Its research combines immunology, chemistry, and data science to create therapies designed to deliver deeper and longer lasting relief for patients.Explore more
Odyssey Therapeutics Org Chart
WR
Executive VP, Head of Small Molecule Research
JH
Executive VP, Enabling Sciences
DP
Executive VP, Nonclinical Development
DD
Executive VP & Head of Nonclinical Developmen...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Odyssey Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Odyssey Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Odyssey Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Odyssey Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Odyssey Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Odyssey Therapeutics has new funding data
Odyssey Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Odyssey Therapeutics launches new products
Earning: See what the market has to say on Odyssey Therapeutics recently announced quarterly report
Recommended Actions
Find VP level buyers at Odyssey Therapeutics
Find 3 more new buyers
Compare Similar Companies to Odyssey Therapeutics
Compare insights from companies similar to Odyssey Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Odyssey Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Odyssey Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Odyssey Therapeutics.
Odyssey Therapeutics financials insights
Gather financial insights about Odyssey Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$218M
2022
Series B
$168M
2023
Series C
$101M
2025
Series D
$213M
2026
IPO
$279M
Odyssey Therapeutics Tech Stack
A closer look at the technologies used by Odyssey Therapeutics
Most Recent Scoops
Earnings
Earnings, Finance
Hiring Plans
Odyssey Therapeutics is hiring in Medical & Health for the first time in 12 months. Areas of expertise include: Biostatistics, Life Sciences, Pharmacovigilance, Trial Master File, Medical Monitoring, Clinical Monitoring, and Clinical Research.
Hiring Plans
Hiring Plans
Odyssey Therapeutics has more open roles in Finance than it has had at any time in the past 12 months. Areas of expertise include: Public Policies, Accruals, Financial Analysis, Netsuite, Process Improvement, Accounting Operations, and Accounting Records.
Hiring Plans
Open Position
Open Position
Odyssey Therapeutics News & Media
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
Odyssey Therapeutics, Inc. announces pricing of its upsized IPO of 15,500,000 shares of its common stock at an IPO price of $18 per share.Odyssey, on second try, snags $279M in an IPO
After withdrawing its initial filing last year, the immune drugmaker rebounded and added to a recent run of sizable new biotech stock offerings — while boosting its haul even higher through a concurrent private deal.Odyssey Therapeutics Appoints Jolie M. Siegel as Executive Vice President, General Counsel
BOSTON, January 21, 2026--Odyssey Therapeutics announced the appointment of Jolie M. Siegel, Executive Vice President, General Counsel.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Odyssey Therapeutics
Sign Up For FreeTo access detailed company insights
Odyssey Therapeutics is a biotechnology company developing precision medicines for autoimmune and inflammatory diseases. The company focuses on targeting early immune signals that drive harmful inflammation, aiming to prevent disease before it progresses. Its research combines immunology, chemistry, and data science to create therapies designed to... Read More
